ReviewKidney international2026
Eligibility, timing, and organ quality: indications and outcomes of kidney transplantation in older patients.
Review in Kidney international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Recommendations for the management of frailty in chronic kidney disease: a consensus report.Nature reviews. Nephrology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Kidney transplantation remains the gold standard treatment for end-stage renal disease. The rising prevalence of this condition, at the same time, contributes significantly to the increasing discrepancy between organ supply and demand, impacting the opportunities for treatment while creating challenges for providers and health care systems worldwide. Driven by demographic shifts, the most significant growth in transplant candidates is observed in the older population. Here, we detail characteristics of older recipients who may benefit most from transplantation, with an emphasis on data-driven assessment for candidate selection while also considering the impact of donor organ quality, donation type, and waiting times. Distinguishing between patients with end-stage renal disease who will benefit from transplantation and those who will derive less or no benefit is essential for providing optimal care to older patients while ensuring responsible stewardship of the limited organ supply. We highlight the advantages of preemptive or expedited transplantation to minimize dialysis exposure and address specific considerations for the peri- and postoperative period. Although living donation remains ideal and will shorten the waiting time, kidneys from older or high kidney donor profile index donors show satisfactory outcomes, particularly for older recipients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.